Organogenesis Holding (NASDAQ: ORGO) reported Q2 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $117.3 million versus the consensus estimate of $115.09 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.